🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Austria / NCT05931783
Recruiting Not applicable

Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery

NCT05931783 · tracked via the Priya Life Science Austria tracker
Phase
Not applicable
Started
2024-03-12
Last updated
2024-03-15

Condition(s) studied

Coronary Artery Disease

Investigational drug(s) / intervention(s)

skeletonized harvesting techniquepedicled harvesting technique

skeletonized harvesting technique: In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in skeletonized technique. Thereby, only the artery itself is harvested.

pedicled harvesting technique: In patients who are randomized to this treatment arm, the left internal thoracic artery will be harvested in pedicled technique. Thereby, the artery will be harvested together with the accompanying veins, the endothoracic fascia and fatty tissue in order to create an 1-2 cm broad pedicle.

Study summary

Internal thoracic arteries can be harvested in skeletonized or pedicled technique. Latest research has posed a potential adverse effect of skeletonizing the internal thoracic arteries on graft patency rates and clinical outcome. Prospective, randomized, multi-centre trials are necessary to investigate the impact of harvesting technique of left internal thoracic artery (LITA) on graft patency rates and clinical outcome after coronary artery bypass grafting.

The HARVITA trial compares skeletonized and pedicled harvesting technique of LITA regarding graft patency rates and patient survival.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion criteria: Primary isolated CABG patients with multi-vessel disease (defined as ≥70 % stenosis of the left anterior descending artery (LAD) and ≥50% stenosis of circumflex and right coronary territory, with or without a ≥50% stenosis of the left main artery). Exclusion criteria: * Age \> 80 years * Planned CABG without LITA use * Preoperative mediastinal radiation therapy * Emergency operation * Minimal invasive coronary artery bypass surgery * Any concomitant cardiac or non-cardiac procedures * Previous cardiac surgery * Known contrast agent allergy * Severe stenosis of the left subclavian artery/ left-sided subclavian steal syndrome * Chronic kidney disease (GFR \<60ml/min/1.73m²) * Life expectancy of less than 5 years * Pregnancy * Hyperthyroidism * Iodine allergy Intraoperative exclusion criteria: * Y/T graft off the LITA graft * LITA sequential grafting * LITA target vessel other than LAD

Primary outcome measure(s)

Trial sites (8)

FacilityCityRegionStatus
Medical University of Graz Graz Austria Not Yet Recruiting
Medical University of Innsbruck Innsbruck Austria Recruiting
Medical University of Vienna Vienna Austria Not Yet Recruiting
University of Duisburg-Essen Essen Germany Not Yet Recruiting
University of Freiburg Freiburg im Breisgau Germany Not Yet Recruiting
University Hospital Gießen Giessen Germany Not Yet Recruiting
University of Jena Jena Germany Not Yet Recruiting
University Hospital Bern Bern Switzerland Not Yet Recruiting

More Medical University Innsbruck trials in Austria

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05931783 on ClinicalTrials.gov ↗ ← All trials in Austria